Corey S Goodman's Net Worth
$390 Million
Who is Corey S Goodman?
Corey S Goodman has an estimated net worth of $390 Million. This is based on reported shares across multiple companies, which include PFIZER INC, Checkmate Pharmaceuticals, Inc., RENOVIS INC, RayzeBio, Inc., Ventyx Biosciences, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Metacrine, Inc., IMPEL NEUROPHARMA INC, Elevation Oncology, Inc., and PRECISION BIOSCIENCES INC.
SEC CIK
Corey S Goodman's CIK is 0001278411
Past Insider Trading and Trends
2008 was Corey S Goodman's most active year for acquiring shares with 22 total transactions. Corey S Goodman's most active month to acquire stocks was the month of May. 2006 was Corey S Goodman's most active year for disposing of shares, totalling 200 transactions. Corey S Goodman's most active month to dispose stocks was the month of March. 2020 saw Corey S Goodman paying a total of $22,140,000.00 for 14,795,091 shares, this is the most they've acquired in one year. In 2020 Corey S Goodman cashed out on 35,822,664 shares for a total of $20,743,395.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PFIZER INC (PFE) Snapshot price: $27.5475
Senior Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +170.79% | 51.87K |
—
|
—
| 82.23K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +587.59% | 24.14K |
—
|
—
| 28.25K |
Feb 28
| |||
Form 4
|
∞
| 4K |
—
|
—
| 4K |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Checkmate Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.75% | -131.65K |
$10.45 | -$1,375,564.42 | 2.16M |
May 13 - May 16
| |||
Form 4
| -6.57% | -160.90K |
$10.39 | -$1,671,823.84 | 2.29M |
May 10 - May 12
| |||
Form 4
| -3.42% | -86.68K |
$10.37 | -$898,920.56 | 2.45M |
May 5 - May 9
| |||
Form 4
| -9.65% | -270.68K |
$10.38 | -$2,809,332.35 | 2.54M |
May 2 - May 4
| |||
Form 4
| -6.34% | -190.03K |
$10.38 | -$1,972,578.78 | 2.81M |
Apr 27 - Apr 29
| |||
Form 4
| -4.15% | -129.78K |
$10.39 | -$1,347,796.50 | 3M |
Apr 22 - Apr 26
| |||
Form 4
| -14.91% | -547.73K |
$10.41 | -$5,700,491.17 | 3.13M |
Apr 19 - Apr 21
| |||
Form 4
|
∞
| 3.67M |
$15.00 |
—
| 3.67M |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RENOVIS INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -558.22K |
—
|
—
|
0
|
May 2
| |||
Form 4
| -12.29% | -38.23K |
$2.40 | -$91,744.80 | 272.82K |
Feb 8
| |||
Form 4
| +4,572.82% | 395K |
—
|
—
| 403.64K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -0.96% | -1.85K |
$3.09 | -$5,725.27 | 191.96K |
Scheduled
|
Dec 18
| ||
Form 4
| -0.95% | -1.85K |
$3.38 | -$6,262.17 | 193.81K |
Scheduled
|
Nov 20
| ||
Form 4
| -18.92% | -45.65K |
$3.64 | -$166,206.22 | 195.66K |
Scheduled
|
Oct 26 - Oct 27
| ||
Form 4
| -2.43% | -6.00K |
$13.62 | -$81,693.76 | 241.31K |
Scheduled
|
Oct 2
| ||
Form 4
| -2.37% | -6.00K |
$14.74 | -$88,448.00 | 247.31K |
Scheduled
|
Sep 1
| ||
Form 4
| -2.31% | -6.00K |
$12.34 | -$74,021.28 | 253.31K |
Scheduled
|
Aug 1
| ||
Form 4
| -2.26% | -6.00K |
$15.33 | -$91,965.79 | 259.31K |
Scheduled
|
Jul 3
| ||
Form 4
| -2.21% | -6.00K |
$16.27 | -$97,613.81 | 265.31K |
Scheduled
|
Jun 1
| ||
Form 4
| -2.16% | -6.00K |
$17.57 | -$105,406.08 | 271.31K |
Scheduled
|
May 1
| ||
Form 4
| +21.65% | 49.35K |
$1.02 | $50,563.40 | 277.31K |
Apr 12
| |||
Form 4
| -5.20% | -12.50K |
$20.28 | -$253,560.00 | 227.96K |
Scheduled
|
Apr 6
| ||
Form 4
| -3.61% | -9.00K |
$20.77 | -$186,961.52 | 240.46K |
Scheduled
|
Apr 3
| ||
Form 4
| -5.28% | -12.50K |
$21.97 | -$274,597.00 | 224.46K |
Scheduled
|
Mar 6
| ||
Form 4
| -3.66% | -9.00K |
$21.96 | -$197,682.78 | 236.96K |
Scheduled
|
Mar 1
| ||
Form 4
| -4.84% | -12.50K |
$20.18 | -$252,258.04 | 245.96K |
Scheduled
|
Feb 6
| ||
Form 4
| -3.37% | -9.00K |
$20.99 | -$188,911.74 | 258.46K |
Scheduled
|
Feb 1
| ||
Form 4
| -1.11% | -3.00K |
$20.00 | -$60,000.00 | 267.46K |
Scheduled
|
Jan 25 - Jan 26
| ||
Form 4
| -4.42% | -12.50K |
$19.00 | -$237,500.00 | 270.46K |
Scheduled
|
Jan 16 - Jan 18
| ||
Form 4
| -2.08% | -6.00K |
$15.18 | -$91,059.50 | 282.96K |
Scheduled
|
Jan 3
| ||
Form 4
| -2.03% | -6.00K |
$15.85 | -$95,123.00 | 288.96K |
Scheduled
|
Dec 1
| ||
Form 4
| -1.99% | -6.00K |
$13.83 | -$82,998.55 | 294.96K |
Scheduled
|
Nov 1
| ||
Form 4
| -1.95% | -6.00K |
$13.49 | -$80,961.00 | 300.96K |
Scheduled
|
Oct 3
| ||
Form 4
| -3.16% | -10.00K |
—
|
—
| 306.96K |
Sep 8
| |||
Form 4
| -1.86% | -6.00K |
$13.27 | -$79,599.00 | 316.96K |
Scheduled
|
Sep 1
| ||
Form 4
| -1.82% | -6.00K |
$15.21 | -$91,250.79 | 322.96K |
Scheduled
|
Aug 1
| ||
Form 4
| -1.79% | -6.00K |
$15.04 | -$90,221.45 | 328.96K |
Scheduled
|
Jul 1
| ||
Form 4
| +854.41% | 25K |
$0.81 | $20,250.00 | 27.93K |
Jun 3
| |||
Form 4
| -1.76% | -6.00K |
$13.52 | -$81,121.84 | 334.96K |
Scheduled
|
Jun 1
| ||
Form 4
| -1.73% | -6.00K |
$14.73 | -$88,380.00 | 340.96K |
Scheduled
|
May 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| -1.70% | -6.00K |
$11.93 | -$71,592.00 | 346.96K |
Feb 1
| |||
Form 4
| -1.67% | -6.00K |
$13.94 | -$83,629.04 | 352.96K |
Jan 3
| |||
Form 4
| -1.64% | -6.00K |
$14.19 | -$85,161.00 | 358.96K |
Dec 1
| |||
Form 4
| -1.62% | -6.00K |
$13.77 | -$82,635.25 | 364.96K |
Nov 24
| |||
Form 4
| +0.84% | 3.09K |
—
|
—
| 370.96K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) Snapshot price: $62.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.16M |
—
|
—
| 5.16M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 4M |
$16.00 |
—
| 4M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||